3rd Biennial Schizophrenia International Research Conference
Conference Home
Abstract Submission
Information
Registration/Housing
CME Information
Meeting Schedule
Science of the Meeting
Travel Information
Travel Fellowships
Faculty
Organizers
Satellite Meetings
   Poster Awards
Contact Information  
Abstract Submission Information


SIRS Abstract Submission Process and Guidelines

Oral and Poster abstract submission is closed.   Symposia abstract submission is closed.

New for 2012: The Program and Organizing Committees will limit the number of presentations for presenter participation in oral presentations and symposia sessions to no more than two presentations per presenter. We hope to increase the number of talented scientists presenting new information.

There will be three types of program proposals for presentation consideration:
 

  1. Symposia – Moderately formal 2 hour panel session with a maximum of 6 participants. Each abstract must have a chair and a discussant. If the Chair elects to have 5 speakers in the session, the Chair will participate as one of the speakers or the discussant. The discussant may not be a speaker or include any slides for the presentation.   Symposia abstract submission is closed. 
  2. Independent Oral Presentations – Abstract submission – 1 presenter, but may have multiple authors.  The presentations will be 10 minutes with an additional 5 minutes for discussion.   In the submission process, presenters will be given the opportunity to accept a poster presentation if not accepted for an oral presentation.  DEADLINE for Submissions – 1 December 2011
  3. Poster – Abstract submission – 1 presenter, but may have multiple authors.  DEADLINE for Submissions – 1 December 2011

All symposia, oral and poster presentation submissions will be reviewed by a Program Committee. 

 

Categories for abstract submission for the 2012 Biennial Conference will be:
 

  1. Adverse Events
  2. Animal Models
  3. Brain Imaging
         a. structural
         b. functional
         c. spectroscopy
  4. Children and adolescents
  5. Diagnostic Issues
  6. Electrophysiology
  7. Epidemiology
  8. Ethical Issues
  9. Genetics
  10. Health Economics
  11. Neurobiology and neurochemistry
  12. Neurodevelopment
  13. Neuropathology
  14. Neurophysiology
  15. Neuropsychology 
  16. Non-pharmacological treatments
  17. Outcome
  18. Psychosocial Functioning
  19. Phenomenology
  20. Psychopharmacology
  21. Quality of Life
  22. Services Research
  23. Substance abuse co-morbidity
  24. Other
  25. Symposium Guidelines

    New for 2012: The number of presentations one speaker may give in symposia sessions and/or oral presentations will be limited to two (2). There is not a limitation to the number of roles one may have as a chair, co-chair and discussant.

  • A symposium is a moderately formal 2 hour session that includes 4 presenters and 1 discussant.
  • Symposium proposals must include both the overall panel proposal, as well as the individual presenter abstracts. The panel chair is responsible for submitting the overall summary and each presenter’s individual presentation abstract. 
  • Each of the 4 presentations lasts 30 minutes which allows for a 20-minute presentation and 10-minute discussion period.
  • One discussant per symposium is required. The discussant cannot also be a presenter. This individual will lead the discussion with panelists and attendees the last 30 minutes of the symposium. NO formal presentation, slides, or other audio visuals are allowed for discussants; this rule will be strictly enforced.
  • Symposium sessions will be scheduled with the assumption that all speakers agree to be available on all days of the Meeting.
  • Symposium participants should be from various institutions (preferably from different countries) so the Meeting attendees get the benefit of cross-institutional collaboration. No more than two presenters may be from the same institution within a symposia session. The chair may be asked to replace a speaker if the abstract submission includes more than two speakers from the same institution.
  • There is a limit of 16,200 characters for the text of your abstract submission. This includes title (200 characters), the overall abstract (3,200 characters) and each speaker's abstract (3,200 characters each), as well as all spaces. No images will be accepted.
  • At the time of submission, the chair must submit his/her disclosures. Disclosures for all other presenters will be required if the symposium is accepted.  
  • Audiovisual equipment available for every symposium: laptop, LCD projector, laser pointer, podium, and microphone.

 

Oral Presentation Guidelines

 

  • Oral Presentation abstracts should be structured as: Background, Methods, Results, and Discussion. Include as much actual data as possible.
  • Oral Presentations will last 10 minutes with an additional 5 minutes for discussion. 
  • There is a limit of 3,200 characters, not counting spaces, for the text of your abstract submission.  No images will be accepted.
  • The presenter will be required to submit a COI disclosure at the time of submission.
  • Submitters will be given the opportunity in the submission process to elect that if the oral presentation is not accepted, then the abstract may be considered for poster presentation.

Poster Presentation Guidelines

 

  • Poster abstracts should be structured as Background, Methods, Results, and Discussion.  Include as much actual data as possible.
  • There is a limit of 3,200 characters, not counting spaces, for the text of your abstract submission.  No images will be accepted. 
  • The presenter will be required to submit a COI disclosure at the time of submission. 
  • Poster boards are .94 meters wide by 2.39 meters.  Push-pins may be used.

  • This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vanderbilt School of Medicine and the Schizophrenia International Research Society. Vanderbilt School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.